Navigation Links
Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference
Date:5/24/2013

LOVELAND, Colo., May 24, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Dr. Robert Grieve , the Company's chairman and chief executive officer, and Jason Napolitano , executive vice president and chief financial officer, will present at the Second Annual Marcum MicroCap Conference, which is being held May 30, 2013 in New York City at the Grand Hyatt Hotel.

The Company's presentation is scheduled to begin at 1:30 p.m. EDT. The Heska group presentation will be available for the public to access via the Company's corporate website, www.heska.com at the time of the presentation and for two weeks thereafter. 

For more information and registration, please visit the conference website: http://www.marcumllp.com/microcap.

About Heska
Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.  

About Marcum LLP
Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation. Ranked among the top 15, Marcum LLP offers the resources of 1,000 professionals, including over 125 partner
'/>"/>

SOURCE Marcum LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Heska Announces Quarterly Dividend of $0.10 Per Share
2. Heska to Present at B. Riley Investor Conference
3. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
4. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
5. Heska Enters Distribution Agreement with MWI Veterinary Supply
6. Heska Reports Third Quarter 2012 Earnings
7. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2012 Earnings Conference Call Webcast
8. Heska Announces 19.0% Revenue Growth for Fourth Quarter of Fiscal 2012
9. Webcast Alert: Heska Corporations Annual Meeting of Stockholders Webcast
10. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
11. Heska Corporation to Present at the 14th Annual B. Riley & Co. Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , Net Sales of $1.17 billion represent a decrease ... increase of 5.7% constant currency , Reported net loss ... earnings per share were $1.59, an increase of 0.6% over ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... 2015.  The Company reported second quarter net sales of $1.17 ...
(Date:7/29/2015)... July 30, 2015  Astellas today announced topline ... the efficacy and safety of intravenous (IV) and ... under development for adults with candidemia and other ... study demonstrated that the trial did not meet ... response in isavuconazole-treated patients at the end of ...
(Date:7/29/2015)... SAN FRANCISCO , July 29, 2015  Nektar Therapeutics ... the second quarter ended June 30, 2015 on Wednesday, August ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3
... YORK, May 19, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0503653/Pharmaceutical-Management-of-Obesity-Technical-Insights.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... a lot of research and product development ...
... 2011 Genomic Health, Inc. (Nasdaq: GHDX ... from ten separate studies at the American Society of ... 2011 at McCormick Place in Chicago.  The company markets ... which is clinically validated to predict chemotherapy benefit as ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights) 2Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 7
(Date:7/30/2015)... ... 30, 2015 , ... New research finds some distinct differences in the way ... on the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, ... cases of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) ...
(Date:7/30/2015)... ... 2015 , ... Political unrest is the number one concern ... survey by leading international insurance provider Clements Worldwide. The "Clements Worldwide Risk Index" ... largest sources of financial losses among respondents. , Twenty-eight percent of top managers ...
(Date:7/30/2015)... ... 2015 , ... HEALTHCAREfirst , the leading provider of cloud-based software, services ... hosting a free webinar detailing the 2016 proposed rule from CMS for home health. ... President of Regulatory Affairs for the National Association for Home Care and Hospice (NAHC), ...
(Date:7/30/2015)... ... July 30, 2015 , ... Case Mason ( http://www.casemason.com ... consumer brands, recently completed a consolidation of all of its production capabilities to ... out of two separate locations situated 11 miles apart. , The advantages of ...
(Date:7/29/2015)... ... 30, 2015 , ... Macro Wealth Management (MWM) Presidents have increased ... Lifetime program by encouraging their clients to donate their MWM planning fees to the ... McClellan and Tim Streid, who see charitable giving as an important part of financial ...
Breaking Medicine News(10 mins):Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2
... Md., July 30, 2009 Continuing to help ensure the ... Convention has revised written and physical standards for the widely ... at the request of the Food and Drug Administration (FDA) ... more than 200 people died as a result of heparin ...
... BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- China Medical ... leading China-based medical device,company that develops, manufactures and markets ... an independent internal,investigation and the expected reporting in late ... fiscal year ended March 31, 2009 and the,quarter ended ...
... injections both seem effective, study says , THURSDAY, ... to the common vaginal infection, bacterial vaginosis, are less ... contraception, whether it be birth control pills or Depo-Provera ... examined medical records for 330 women with a mean ...
... , , ... Blue Shield of Texas (BCBSTX) joined other Blue Plans today to ... health care cost information tool, developed by WellPoint, which is called ... than 48 million American consumers will have access to valuable cost ...
... , , ... line-item vetoed the Department of Public Health,s Domestic Violence ... centers. , , Services provided by these ... orders, counseling and other vital support services. , ...
... TREVOSE, Pa., July 30 Rita,s Italian Ice, ( ... concept with more than 550 stores across 18 states, today announced ... Foundation for Childhood Cancer (ALSF) during its signature paper lemon fundraiser. ... Rita,s has collectively raised more than $2 million for pediatric cancer ...
Cached Medicine News:Health News:Patient safety advanced by revised heparin standards 2Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 2Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 3Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 4Health News:Birth Control May Help Ward Off Bacterial Vaginosis 2Health News:Birth Control May Help Ward Off Bacterial Vaginosis 3Health News:Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency, Expand Access to Health Care Cost Information 2Health News:Governor Eliminates Funding to Domestic Violence Programs 2Health News:Rita's Squeezes Pediatric Cancer with $451,000 Donation 2Health News:Rita's Squeezes Pediatric Cancer with $451,000 Donation 3
The 3.0 mm Cannulated Screw can be used with or without threaded washer. Uses 1.1 mm threaded or non-threaded guide wire. , ,The Threaded Washer provides a recessed internal buttress which allows the...
... BIAX Total Wrist System was the first wrist ... normal wrist. Since then it has become the ... , ,During total wrist replacement surgery, doctors remove ... joint replacement implant in place of the damaged ...
... a simple, effective instrument to grasp soft tissue ... and loop. The grasping function of the instrument ... and precisely place a stitch up to 1 ... all in one quick step. The sterile, single ...
... Punch Forceps provide superior tissue excision with ... an aggressive tooth pattern to capture loose ... a unique stress pin buffering system to ... use, the stress pin buffering system applies ...
Medicine Products: